Suvannasankha, A., Li, M., Omofuma, O. O., Hampp, C., Phelan, M., Breskin, A., Shao, P., Roccia, T., Mukherjee, N., Shrestha, A., Lee, D. J., Glass, J., Knorr, K., Kroog, G. S., Rodriguez-Lorenc, K. (2025). Second primary malignancy (SPM) in patients (pts) with multiple myeloma (MM) receiving chimeric antigen receptor T-cell (CAR T) therapy or other systemic anticancer therapy (SACT): A comparative study using a real-world database.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7519